OXURION (EBR:OXUR) | WebDisclosure

Basculer en Français

9819	Companies
197030	Keywords
128079	Articles
104774	Press releases

Home
Companies
OXURION

PRESS RELEASE

published on 07/17/2025 at 08:30, 6 months 20 days ago

Oxurion Secures Financing for the Acquisition of Axiodis CRO and Targets Closing on August 1, 2025
Oxurion NV secures financing for 72% stake in Axiodis CRO, enhancing its clinical data capabilities. Acquisition aligned with strategic roadmap for European hub. Closing set for August 1, 2025

Acquisition Clinical Data Oxurion NV Axiodis CRO European Hub
PRESS RELEASE

published on 07/17/2025 at 08:30, 6 months 20 days ago

Oxurion verzekert financiering voor de overname van Axiodis CRO en beoogt een closing op 1 augustus 2025
Oxurion sichert Finanzierung für die Übernahme von Axiodis CRO ab und plant Abschluss der Transaktion am 1. August 2025

Übernahme Finanzierung Oxurion Klinische Daten Therapeutische Entwicklung
BRIEF

published on 07/15/2025 at 18:05, 6 months 21 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC

Shares Transparency Atlas Biopharmaceutical Oxurion
BRIEF

published on 07/15/2025 at 18:05, 6 months 21 days ago

Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC

Actions Atlas Transparence Biopharmaceutique Oxurion
PRESS RELEASE

published on 07/15/2025 at 18:00, 6 months 21 days ago

Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding threshold crossing under Belgian Transparency legislation

Transparency Notification Shareholding Oxurion NV Belgian Legislation Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/15/2025 at 18:00, 6 months 21 days ago

Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC
Oxurion NV meldt ontvangst van transparantiekennisgeving en verlaagd aandelenposities onder wettelijke drempel. Biofarmaceutisch bedrijf in Leuven actief op gebied van therapeutische innovatie en klinisch onderzoek

Transparantiekennisgeving Euronext Brussel Oxurion NV Leuven Biofarmaceutisch
BRIEF

published on 07/14/2025 at 18:05, 6 months 22 days ago

Oxurion Announces Transparency Notifications from Atlas

Biopharmaceutical Shareholder Notification Atlas Special Opportunities Oxurion NV Transparency Legislation
BRIEF

published on 07/14/2025 at 18:05, 6 months 22 days ago

Oxurion annonce les notifications de transparence d'Atlas

Biopharmaceutique Notification Aux Actionnaires Oxurion NV Opportunités Spéciales Atlas Législation Sur La Transparence
PRESS RELEASE

published on 07/14/2025 at 18:00, 6 months 22 days ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC, in accordance with Belgian Transparency legislation

Shareholding Oxurion NV Belgian Legislation Transparency Notifications Atlas Special Opportunities II LLC
PRESS RELEASE

published on 07/14/2025 at 18:00, 6 months 22 days ago

Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC
Oxurion NV heeft transparantiekennisgevingen ontvangen volgens de Belgische wetgeving betreffende belangrijke deelnemingen. Atlas Special Opportunities II LLC heeft aanzienlijke aandelen in Oxurion verworven en verkocht. Raadpleeg www.oxurion.com voor meer informatie

Transparantiekennisgevingen Oxurion NV Biofarmaceutisch Belgische Wetgeving Atlas Special Opportunities II LLC

Accesswire

Published on 02/06/2026 at 13:30, 1 hour 8 minutes ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 13:30, 1 hour 8 minutes ago

Canex Metals Acquires 51.93% of Gold Basin and Seeks a Court-Appointed Annual General Meeting of Gold Basin Shareholders
Published on 02/06/2026 at 13:00, 1 hour 38 minutes ago

Revolve Announces US$40 Million Strategic Financing With Callaway Capital
Published on 02/06/2026 at 08:00, 6 hours 38 minutes ago

Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 03:50, 10 hours 48 minutes ago

High Tide Resources annonce des placements privés sans courtier

View all ACCESSWIRE

EQS Group

Published on 02/06/2026 at 14:15, 23 minutes ago

Phemex Introduces 24/7 TradFi Futures Trading with 0-Fee Carnival, Creating an All-in-One Trading Hub
Published on 02/06/2026 at 14:05, 33 minutes ago

AITO and ADM Enter into Strategic Partnership, Marking a New Chapter in the Global Expansion of Intelligent Luxury
Published on 02/06/2026 at 14:00, 38 minutes ago

TCL Elevates Olympic Winter Games for Fans and Athletes at Milano Cortina 2026, Empowering Audiences Worldwide with Vision of "It's Your Greatness"
Published on 02/06/2026 at 13:47, 51 minutes ago

EQS-Adhoc: R. STAHL Supervisory Board elects Prof. Dr. Peter Hofmann as new Chairman
Published on 02/06/2026 at 13:35, 1 hour 3 minutes ago

DeFi Technologies and Valour Partner with MERGE to Host DeFi Technologies Insights Symposium in São Paulo

Les Echos

Published on 02/06/2026 at 07:54, 6 hours 44 minutes ago

ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026
Published on 02/05/2026 at 19:24, 19 hours 13 minutes ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 19:24, 19 hours 13 minutes ago

Compte-Rendu de l’Assemblée Générale Mixte
Published on 02/05/2026 at 19:15, 19 hours 23 minutes ago

ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 02/05/2026 at 19:15, 19 hours 23 minutes ago

ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES JANVIER 2026

View all LES ECHOS COMFI WIRE